Topics

Explore topics

#growthstock

Follow to get notified about new posts with this tag
s1241003
biotech
8y
Biofrontera, Opportunities After FDA Approval
Biofrontera, Opportunities After FDA Approval
Summary Ameluz (nano emulsion) is superior to former formulation Levulan (actinic kreatoses) and Metvix (basal cell carcinoma). FDA approval for Ameluz as treatment for basal cell carcinoma is likely to
4
2

Discover communities

Explore communities
Create your community